We are pleased to announce two new appointments in the CRUK funding committee: Professor Kairbaan Hodivala-Dilke has joined as the new chair of CRUK Research Careers Committee and Prof Simon Boulton as Chair of CRUK Discovery Research Committee.
New Startup of the Year: Adendra Therapeutics Ltd (Caetano Reis e Sousa Co-funder)
Startup Achievement of the Year: Achilles Therapeutics UK (Sergio Quezada CSO)
Government commits nearly half a billion pounds for UK research to cover EU shortfall
The Business Secretary has announced up to £484 million in research funding to support the R&D sector, in response to the EU’s refusal to finalise the UK’s association to Horizon Europe and other related EU science programmes as agreed under the Trade and Cooperation Agreement (TCA) in 2020. Read more
Other funding opportunities NIHR allocates funding for bone metastasis research
The national Institute for Health and Care Research (NIHR) has launched a new funding call for research into bone metastasis, following the identification of this area of unmet need by NCRI. The treatment of bone metastases poses a significant health and economic burden and occurs in 7 out of every 10 people with advanced cancer. Applications must be submitted online no later than 1pm on 4 January 2023. Applications will be considered by the HTA Funding Committee at its meeting in March 2023. More information can be found here
Events
3D Models of the Tumour Micro-environment Workshop
Date and venue 15th February 2023
UCL Centre for 3D models of Health and Disease - Charles Bell House on the Bloomsbury Campus
Organised by Prof Frances Balkwill (QMUL) and Prof Umber Cheema (UCL) Register using this linkand email cruk.cityoflondoncentre@ucl.ac.uk for password
This event is exclusively for CoL Centre members
Joint CRUK CoL Centre Theme 2/RadNet Meeting
Date and venue 3rd March 2023
Barts Cancer Institute, QMUL _ Joseph Rotblat building Register using this link and email cruk.cityoflondoncentre@ucl.ac.uk for password This event is exclusively for CoL Centre members
.
Public and Patient Involvement and Engagement Workshop
Date and Venue 16th March 2022, 9.30 - 4.00 pm
James Clerk Maxwell Building, KCL, 57 Waterloo Rd London SE1 8WA
Would you like to learn more about PPIE? Join us for a day full of talks about - Training resources - Funding available - Activities that are happening - How to get involved
This event is exclusively for CRUK CoL Centre Members (UCL, BCI, KCL, Crick) and invited speakers
For more info and registration, click here
CRUK partnership with Nivea was launched in July 2012 to raise vital funds for skin cancer research. To celebrate the 10th anniversary this week, Barts Cancer Institute has hosted a group of Nivea members for a lab tour and chat with Prof Vicky Sanz Moreno about her melanoma research.
Public and patient involvement and engagement workshop: best practise
Date and time 16th March, 9.30am - 4pm
CTC Building, 90 Tottenham Court Road
If you would like to engage or PPIE or if you are already doing it, this workshop will help you to start or improve your journey!
Would you like to learn more about PPIE?
Join us for a day full of talks about
Training resources
Funding available
Activities that are happening
How to get involved
This event is exclusively for CRUK CoL Centre Members (UCL, BCI, KCL, Crick) and invited speakers Register here
Meet Our RadNet Community,
Meet Dr Kasper Fugger
RadNet Group Leader
His lab studies how some rare and cytotoxic nucleotides affect cancer cell viability, activation of stress response pathways and anti-tumour immunity. They recently discovered a process whereby cells eliminate cytotoxic nucleotides that are formed during normal metabolism and that targeting this process sensitise cancer cells to PARP inhibitor therapy and can overcome acquired resistance (Fugger et al, Science 2021). In addition to nucleotide metabolism, these cytotoxic nucleotides are also produced following ionising radiation (IR) treatment. In the lab Kasper's group are using metabolomics, genome-wide CRISPR screens, cell biology and biochemistry to analyse the formation of these IR-induced nucleotides and trying to uncover the molecular mechanisms that governs the cellular responses to them, such as DNA repair. Their goal is to translate new discoveries into more effective radio- and chemotherapies for the benefit of cancer patients.
New Publication:
Dr Jamie Dean has published a paper on; 'Phase I study of a novel glioblastoma Radiation Therapy schedule exploiting cell-state plasticity' in the journal of Neuro-Oncology.
Congratulations to Dr Jamie Dean, Dr Catarina Veiga and Dr Lisa Whittaker on being awarded one of the 11 UCL Beacon Bursaries
They have been awarded funding for a Special Podcast Series with Teenagers & Young Adults, Radiation Researchers & Therapeutic Radiographers. This project will build on our public engagement project, Radiation Reveal, which highlighted less is known about radiotherapy compared to other cancer treatments. The aim is to increase awareness of radiotherapy, Teenage and young adult's experiences of cancer, impactful PPIE and promote UCL’s cancer research to new audiences outside of the academic domain.
Watch this space on updates to the project and hearing the podcasts.
Wisdom from ‘The West’ Conference
When: Wednesday 15th – Friday 17th March 2023 Where: The Hyatt Regency, Manchester
Registration is openfor the Wisdom from ‘The West’ Conference,at The Hyatt Regencyin Manchester.
The conference is in honour of Professor Catharine West who is retiring in December 2022.
We are looking forward to showcasing areas where Catharine has made her mark, not only looking back but also looking to the future in radiobiology and biomarker research.
Catharine has an international reputation that is reflected by our confirmed speakers who will be travelling from across the UK, Europe, and the USA to join us, such as Jens Overgaard, George Wilson, Javier Torres-Rocca, Heidi Lyng, Mike Joiner and many more!
Please follow this linkfor registration and further details on the conference packages, accommodation etc.
CRUK RadNet City of London and the European Working Group on the Radiobiology of Molecular Radiotherapy are delighted to announce that the 2nd International Workshop on Radiobiology of Molecular Radionuclide Therapy (IWRMR) symposium and workshop will take place as a face-to-face event (with an online observation option) from 13th to 14th March 2023 at the Francis Crick Institute. The meeting provides a broad platform for presentation of cutting–edge radionuclide biological radiation research, with space to discuss lessons learned from external beam radiotherapy. The workshop will also facilitate the development of new collaborations in dedicated sessions that complement the oral and poster presentations.
ational Institute for Health and Care Research (NIHR) has launched a new funding call for research into bone metastasis, following the identification of this area of unmet need by NCRI. The treatment of bone metastases poses a significant health and economic burden and occurs in 7 out of every 10 people with advanced cancer. Applications must be submitted online no later than 1pm on 4 January 2023. Applications will be considered by the HTA Funding Committee at its meeting in March 2023. 
